5 mins | 30 mins | Hourly | Daily | Weekly |
---|---|---|---|---|
BUY | BUY | BUY | SELL | SELL |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MA5 | 6.68▲ | 6.59▲ | 6.55▲ | 6.65▲ | 6.59▲ |
MA10 | 6.66▲ | 6.53▲ | 6.60▲ | 6.75▼ | 7.24▼ |
MA20 | 6.59▲ | 6.60▲ | 6.66▲ | 6.58▲ | 7.68▼ |
MA50 | 6.51▲ | 6.66▲ | 6.66▲ | 7.35▼ | 13.01▼ |
MA100 | 6.58▲ | 6.67▲ | 6.68▲ | 7.74▼ | 16.76▼ |
MA200 | 6.65▲ | 6.65▲ | 6.76▼ | 11.31▼ | 23.26▼ |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MACD | 0.011▲ | 0.020▲ | -0.006▼ | 0.063▲ | 0.210▲ |
RSI | 74.134▲ | 56.742▲ | 53.745▲ | 47.056▼ | 33.762▼ |
STOCH | 81.695▲ | 71.478 | 44.784 | 38.487 | 19.787▼ |
WILL %R | -7.692▲ | -18.868▲ | -30.645 | -52.381 | -74.251 |
CCI | 126.154▲ | 138.772▲ | 19.339 | -45.882 | -79.712 |
Thursday, May 16, 2024 02:53 PM
REPL stock results show that Replimune Group missed analyst estimates for earnings per share the fourth quarter of 2024.More From InvestorPlace The #1 AI Investment Might Be This Company You’ve Never ...
|
Thursday, May 16, 2024 06:59 AM
Twelve-month primary analysis results by independent central review from the IGNYTE clinical trial of RP1 (vusolimogene oderparepvec) in anti-PD1 ...
|
Wednesday, May 15, 2024 05:00 PM
Sources: FactSet, Dow Jones Stock Movers: Gainers, decliners and most actives market activity tables are a combination of NYSE, Nasdaq, NYSE American and NYSE Arca listings. Sources: FactSet ...
|
date | open | high | low | close | volume |
---|---|---|---|---|---|
16/05/24 | 6.70 | 6.75 | 6.29 | 6.72 | 927,250 |
15/05/24 | 6.92 | 6.96 | 6.72 | 6.81 | 553,697 |
14/05/24 | 6.64 | 7.01 | 6.54 | 6.71 | 528,023 |
13/05/24 | 6.43 | 6.84 | 6.43 | 6.58 | 407,780 |
10/05/24 | 6.76 | 6.95 | 6.38 | 6.41 | 390,601 |
09/05/24 | 6.65 | 6.79 | 6.51 | 6.73 | 520,383 |
08/05/24 | 6.78 | 6.83 | 6.57 | 6.68 | 926,000 |
07/05/24 | 7.04 | 7.27 | 6.83 | 6.88 | 475,859 |
06/05/24 | 7.22 | 7.24 | 6.93 | 7.01 | 412,090 |
03/05/24 | 6.80 | 7.08 | 6.605 | 6.95 | 631,256 |
|
|
||||
|
|
||||
|
|